GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Doximity Inc (NYSE:DOCS) » Definitions » EBIT

DOCS (Doximity) EBIT : $201.9 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Doximity EBIT?

Doximity's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2024 was $55.4 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was $201.9 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Doximity's annualized ROC % for the quarter that ended in Sep. 2024 was 53.17%. Doximity's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 470.39%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Doximity's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 2.24%.


Doximity EBIT Historical Data

The historical data trend for Doximity's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Doximity EBIT Chart

Doximity Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EBIT
Get a 7-Day Free Trial 22.16 53.30 113.54 125.11 171.81

Doximity Quarterly Data
Mar19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.73 58.55 41.85 46.05 55.45

Competitive Comparison of Doximity's EBIT

For the Health Information Services subindustry, Doximity's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Doximity's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Doximity's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Doximity's EV-to-EBIT falls into.



Doximity EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $201.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Doximity  (NYSE:DOCS) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Doximity's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

ROC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=221.784 * ( 1 - 28.98% )/( (304.276 + 288.15)/ 2 )
=157.5109968/296.213
=53.17 %

where

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1073.458 - 18.694 - ( 750.488 - max(0, 135.277 - 908.466+750.488))
=304.276

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1118.516 - 24.808 - ( 805.558 - max(0, 132.283 - 957.712+805.558))
=288.15

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Doximity's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=221.784/( ( (24.721 + max(24.891, 0)) + (22.592 + max(22.093, 0)) )/ 2 )
=221.784/( ( 49.612 + 44.685 )/ 2 )
=221.784/47.1485
=470.39 %

where Working Capital is:

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(120.91 + 0 + 37.068) - (18.694 + 102.943 + 11.45)
=24.891

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(124.793 + 0 + 27.361) - (24.808 + 93.751 + 11.502)
=22.093

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Doximity's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2024 )
=201.902/9003.650
=2.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Doximity EBIT Related Terms

Thank you for viewing the detailed overview of Doximity's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Doximity Business Description

Traded in Other Exchanges
N/A
Address
500 3rd Street, Suite 510, San Francisco, CA, USA, 94107
Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.
Executives
Anna Bryson officer: Chief Financial Officer C/O DOXIMITY, INC., 500 3RD STREET SUITE 510, SAN FRANCISCO CA 94107
Kira Scherer Wampler director C/O DOXIMITY, INC., 500 3RD STREET, SUITE 510, SAN FRANCISCO CA 94107
Timothy S Cabral director C/O VEEVA SYSTEMS INC., 4280 HACIENDA DRIVE, PLEASANTON CA 94588
Yang Watkin Phoebe L. director C/O DOXIMITY, INC., 500 THIRD STREET, SAN FRANCISCO CA 94107
Craig Overpeck officer: See Remarks C/O DOXIMITY, INC., 500 THIRD STREET, SUITE 510, SAN FRANCISCO CA 94107
Jeffrey Tangney director, 10 percent owner, officer: Chief Executive Officer C/O DOXIMITY, INC., 500 3RD STREET SUITE 510, SAN FRANCISCO CA 94107
Paul W. Jorgensen officer: Chief Revenue Officer 500 THIRD STREET, SUITE 510, SAN FRANCISCO CA 94107
Gilbert H Kliman director, 10 percent owner C/O INTERWEST PARTNERS, 467 FIRST STREET SUITE 201, LOS ALTOS CA 94022
Emergence Capital Partners Ii Lp 10 percent owner 160 BOVET ROAD, SAN MATEO CA 94402
Emergence Equity Partners Ii, L.p. 10 percent owner 160 BOVET ROAD, SUITE 300, SAN MATEO CA 94402
Emergence Gp Partners, Llc 10 percent owner PIER 5, THE EMBARCADERO, STE 102, SAN FRANCISCO CA 94111-2094
Kevin Spain director C/O EMERGENCE CAPITAL, 160 BOVET ROAD, STE. 300, SAN MATEO CA 94402
Emergence Capital Opportunity I, L.p. 10 percent owner 160 BOVET ROAD, SUITE 300, SAN MATEO CA 94402
Emergence Equity Partners Vi, L.p. 10 percent owner C/O EMERGENCE CAPITAL PARTNERS, 160 BOVET ROAD, SUITE 300 CA SAN MATEO
Regina M. Benjamin director 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453